Besvil 200 Octacaps

Fluticasone Furoate and Vilanterol Powder for Inhalation
Besvil 200 Octacaps
Besvil 200 Octacaps is prescribed for the treatment of chronic obstructive pulmonary disease.

Besvil 200 Octacaps Composition :-

• Fluticasone is a corticosteroids.
• Vilanterol is a long-acting beta-agonists (LABAs).

Besvil 200 Octacaps Uses :-

Besvil 200 Octacaps is used to control wheezing, coughing, shortness of breath and chest tightness caused by asthma and chronic obstructive pulmonary.

Besvil 200 Octacaps Dosage :-

Besvil 200 Octacaps is a prescription medicine. Take Besvil 200 Octacaps as directed by your doctor. 
The dosage of Besvil 200 Octacaps depends on the response to the treatment and the medical condition.
Never self-medicate or change the dosage without a doctor's advice.
Do not stop taking Besvil 200 Octacaps without asking your doctor.

Besvil 200 Octacaps Side-effects :-

Like all medicines, Besvil 200 Octacaps can cause side effects, however not everyone may experience these side effects.
• Headache,
• Runny nose,
• Joint pain,
• Nervousness,
Most of these side effects are short term and get resolved with time. Although, if any of these side effects do not resolve with time or get poor, take a doctor's consultation as soon as possible.

How Besvil 200 Octacaps Works :-

Besvil 200 Octacaps consists of : Fluticasone Furate and Vilanterol Trifenatate.
Fluticasone and Vilanterol works by relaxing and opening air passages in the lungs, making it easier to breathe.
Thus, Besvil 200 Octacaps that control wheezing, coughing, shortness of breath and chest tightness.

Precautions Warnings :-

• Do not take Besvil 200 Octacaps, if you are allergic to fluticasone furate and vilanterol trifenatate.

Besvil 200 Octacaps Mfg By :-

Sun Pharmaceutical Industries Ltd

Besvil 200 Octacaps Price :-

MRP ₹ = 545.00 (30caps)

Besvil 200 Octacaps Storage :-

Besvil 200 Octacaps : store below 30°C

Classification :-

Therapeutics Indiaction : Treatment of Chronic Obstructive Pulmonary Disease
n
Post a Comment (0)
Previous Post Next Post